We don't know much about this study yet.We're trying to become the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.
Male pattern hair loss could hint at androgens affecting COVID-19 severity.
Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.
Consider benefits and risks of new alopecia treatments for safety.